Therapeutic Modalities on Exercise Performance and Post-exercise Recovery of CrossFit® Athletes

Sponsor
University of Nove de Julho (Other)
Overall Status
Recruiting
CT.gov ID
NCT05985967
Collaborator
(none)
12
1
4
23
15.9

Study Details

Study Description

Brief Summary

Crossfit® is a training modality that consists in functional movements, constantly varied and executed at high intensity. Both training sessions and competitions involve physically demanding activities, which in addition to being performed at very high intensity also involves the aerobic metabolism pathway. These characteristics led to very high metabolic and muscular stress, as well as decrease in physical performance immediately after competitions and training sessions. The cumulative effects of the metabolic and muscular stress can be a precursor of injuries. Studies using different therapeutic modalities aiming to improve post-exercise recovery are needed in order to tackle this issue.

However, to the date there are no studies investigating the effects of different therapeutic modalities in an exercise modality such as Crossfit®. Therefore, the aim of this project is to assess the effects of different therapeutic modalities on performance and muscle recovery of Crossfit® athletes.

Condition or Disease Intervention/Treatment Phase
  • Device: PBMT-sMF
  • Device: Shock wave
  • Device: Pneumatic compression
  • Other: Passive recovery
N/A

Detailed Description

It will be carried out a randomized, crossover, controlled trial.

Volunteers will be allocated to four interventions, and the order of the interventions will be randomized.

The outcomes will be obtained at baseline (prior to the Workout of the Day - WOD), and in different timepoints after that.

The WOD will be consisted in finishing as quickly as possible a sequence of three exercises (Calories in Assault AirBike®, Hang Squat Clean and Box Jump Over), in a well-known series model for the athletes, without rest.

The investigators will analyze: the maximum number of free squats performed in 1 minute; the activity of creatine kinase (CK); the levels of Interleukin-6 (IL-6); the ratings of perceived exertion; and the volunteers satisfaction with the interventions.

All data will be analyzed both in their absolute values and in relation to their percentage variation from the values obtained in the pre-WOD (baseline) assessments.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
12 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Therapeutic Modalities on Exercise Performance and Post-exercise Recovery of CrossFit® Athletes
Actual Study Start Date :
Aug 9, 2023
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Control

Passive recovery for 30 minutes

Other: Passive recovery
Volunteers laid in supine position resting for 30 minutes.

Experimental: PBMT-sMF

Photobiomodulation therapy combined with static magnetic field, with a total treatment duration lasting for around 30 minutes.

Device: PBMT-sMF
PBMT-sMF applied in the lower limbs with different doses per muscle group.

Active Comparator: Shock wave

Shock wave therapy applied for 30 minutes.

Device: Shock wave
Shock wave therapy applied in the lower limbs for 30 minutes.

Active Comparator: Pneumatic compression

Pneumatic compression applied for 30 minutes.

Device: Pneumatic compression
Pneumatic compression applied in the lower limbs for 30 minutes.

Outcome Measures

Primary Outcome Measures

  1. Change in functional capacity [1hour, 24 hours and 48 hours after WOD (workout of the day).]

    The functional capacity will be assessed through the maximum number of free squat repetitions performed within 1 minute.

Secondary Outcome Measures

  1. Change in the activity of creatine kinase (CK) [1 hour, 24 hours and 48 hours after WOD (workout of the day).]

    The activity of CK will be analyzed from the blood samples collected from the participants through spectrophotometry and using specific reagent kits.

  2. Change in the levels of interleukin-6 (IL-6) [1 hour, 24 hours and 48 hours after WOD (workout of the day).]

    The levels of interleukin-6 will be analyzed from the blood samples collected from the participants through enzyme-linked immunosorbent assay (ELISA) and using specific reagent kits.

  3. Participants' perceived exercise intensity [1 minute after WOD (workout of the day), 1 minute post-treatment/intervention, 1 hour, 24 hours and 48 hours after WOD.]

    The perception of exercise intensity will be assessed through a 0-100 Ratings of Perceived Exertion Scale: in this scale lower score, means lower degree of fatigue and higher score, means higher degree of fatigue.

  4. Participants' satisfaction regarding the interventions [48 hours after WOD (workout of the day).]

    The participants satisfaction regarding the interventions will be assessed through the LIKERT scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Crossfit® amateur male athletes

  • Do not present a history of musculoskeletal injury in the regions of the hips, knees and calves in the month preceding the study;

  • Are not using pharmacological agents;

  • Athletes should have been practicing the sport for at least 1 year;

  • Voluntarily commit to participate in all stages of the study.

Exclusion Criteria:
  • Present musculoskeletal or joint injuries during data collection.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Laboratory of Phototherapy and Innovative Technologies in Health São Paulo Brazil 01504-001

Sponsors and Collaborators

  • University of Nove de Julho

Investigators

  • Principal Investigator: Ernesto Cesar Pinto Leal Junior, Ph.D., Full Professor

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ernesto Cesar Pinto Leal Junior, Professor, University of Nove de Julho
ClinicalTrials.gov Identifier:
NCT05985967
Other Study ID Numbers:
  • 3.997.120-1
First Posted:
Aug 14, 2023
Last Update Posted:
Aug 14, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes

Study Results

No Results Posted as of Aug 14, 2023